Skip to main content

Precision Medicine

There does not exist a cookie-cutter approach to treating patients with cancer, due to a multitude of patient-related factors, such as gender, race, age, biomarkers, and comorbidities. Despite these factors, which may affect how individuals respond to specific therapeutic protocols, there are general guidelines, including those published by the National Comprehensive Cancer Network (NCCN),1 which can be used to help guide treatment practices to promote optimal clinical outcomes. Read More ›

Data aggregation and management challenges for community oncology practices are becoming more complicated with the advent and application of precision medicine. As advances are made in clinical molecular technologies, and the volume, velocity, and value of this data increases, adjustments must be made to incorporate informatics approaches to inform data-driven decision-making through robust and reliable integration of multiple heterogeneous data sources into one consolidated analytics platform. Read More ›

Once patients are diagnosed with cancer, they begin their journey by forming new relationships with a multidisciplinary healthcare team that will support them during various points along the way. The definition of the patient journey has been broadened to answer important questions on how patients enter the healthcare system. Read More ›

Genetic alterations in molecular pathways are involved in tumor development, survival, and progression. Precision cancer medicine is about using the cancer genome to guide treatment decisions, according to Christine M. Walko, PharmD, BCOP, Personalized Medicine Pharmacologist, Personalized Medicine Clinical Service, and Chair, Clinical Genomic Action Committee, Moffitt Cancer Center, Tampa, FL. Read More ›